For: | Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94 [PMID: 33968307 DOI: 10.4330/wjc.v13.i4.82] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v13/i4/82.htm |
Number | Citing Articles |
1 |
Paraschos Archontakis-Barakakis, Damianos G. Kokkinidis, Sanjana Nagraj, Vipul Gidwani, Theodoros Mavridis, George Ntaios. Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine 2022; 23(10) doi: 10.31083/j.rcm2310334
|
2 |
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani, Renzo M Lombardo. Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation. World Journal of Cardiology 2022; 14(11): 576-598 doi: 10.4330/wjc.v14.i11.576
|
3 |
Paraschos Archontakis‐Barakakis, Weijia Li, Dimitrios Kalaitzoglou, Lazaros Tzelves, Apostolos Manolopoulos, Stefanos Giannopoulos, Grigorios Giamouzis, George Giannakoulas, Apostolos Batsidis, Leonidas Palaiodimos, George Ntaios, Gregory Y. H. Lip, Damianos G. Kokkinidis. Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta‐analysis of 92 studies. British Journal of Clinical Pharmacology 2022; 88(11): 4663 doi: 10.1111/bcp.15464
|
4 |
Paraschos Archontakis Barakakis, Damianos G. Kokkinidis, Weijia Li, Sanjana Nagraj, Spyros Peppas, Michail Kladas, Dimitrios Schizas, Panagiotis Korantzopoulos, George Ntaios. Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation. Journal of Clinical Gastroenterology 2023; 57(10): 1045 doi: 10.1097/MCG.0000000000001796
|
5 |
Theodoros Mavridis, Paraschos Archontakis-Barakakis, David-Dimitris Chlorogiannis, Andreas Charidimou. Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis. International Journal of Stroke 2025; doi: 10.1177/17474930251360076
|
6 |
Ma Carmen Montero-Balosa, Juan A. Limón-Mora, Ana Leal-Atienza, Beatriz García-Robredo, Pablo Sánchez-Villegas, Rebeca Isabel-Gómez, Ma José Aguado-Romeo, Luis Gabriel Luque Romero, Ma Teresa Molina-López. Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study). Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1548298
|